“GlaxoSmithKline, seeking to take advantage of just that, has announced a four year deal with 23andMe that allows them access to everyone’s genetic information for precisely the purposes pertaining to drug research.
In some ways, it was obtuse or naive to assume the online genetic testing frenzy was ever to end well.
Essentially, UK based GlaxoSmithKline, one of the world’s largest pharmaceutical ventures, just paid $300 million to sift through thousands upon thousands of genetic records of people who are primarily unaware or apathetic to the consequences of such activity.” https://thevaccinereaction.org/2019/03/popular-dna-testing-company-signs-300-million-deal-with-big-pharmaceutical-company/?fbclid=IwAR0BtT3zR3rKfgcQ9FQO6IsdMSV0K87dv86RIWve-P-Bpra5iRKsQCU6JZY
Copyright©2019 Families4vaccinechoice
Disclaimer: Information provided on this website is for informational purposes
only and should not be construed as medical or legal advice
Families4vaccinechoice 